Literature DB >> 24215170

Role of nitric oxide synthase genes in hepatitis E virus infection.

R K Hazam1, M Deka, P Kar.   

Abstract

Hepatitis E virus (HEV) is the most common cause of endemic and epidemic acute hepatitis. A correlation between iNOS, eNOS polymorphisms, levels and severity of disease has been reported, and here, we examined the role of iNOS and eNOS gene polymorphisms and their levels in HEV-related acute viral hepatitis and acute liver failure. Hepatitis E virus-related cases of acute hepatitis (294 patients) and liver failure (82 patients) and age- and sex-matched healthy controls (331 subjects) were included in the study. PCR-RFLP was performed to identify the polymorphisms in the iNOS and eNOS genes. iNOS and eNOS levels were studied using ELISA assays and HEV viral load, genotype and combined effects of iNOS genotype, levels and parameters for disease severity were examined. The frequency of iNOS (CT + TT) and eNOS (GT + TT) genotypes was higher in subjects with liver failure compared with controls. iNOS and eNOS levels in patients with acute liver failure (55.51 ± 6.33 IU/mL, 60.2 ± 3.69) cases were significantly increased as compared to patients with acute viral hepatitis (17.8 ± 6.08 IU/mL, 23.7 ± 6.57) and controls (P < 0.05). A significant positive correlation was observed between the iNOS and eNOS levels in our study population when compared with the severity of disease parameters. Hence, the iNOS C150T polymorphism and the eNOS G894T polymorphism and high levels of iNOS and eNOS are associated with an increased risk of HEV-related acute hepatitis and liver failure. This study supports the possible role of nitric oxide synthase genes (iNOS and eNOS) in determining the severity of HEV infection.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  eNOS; hepatitis E; iNOS; nitric oxide synthase; polymorphism

Mesh:

Substances:

Year:  2013        PMID: 24215170     DOI: 10.1111/jvh.12186

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure.

Authors:  Marek Saracyn; Marek Brytan; Robert Zdanowski; Tomasz Ząbkowski; Przemysław Dyrla; Janusz Patera; Stanisław Wojtuń; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 2.  Nitric oxide in liver diseases.

Authors:  Yasuko Iwakiri; Moon Young Kim
Journal:  Trends Pharmacol Sci       Date:  2015-05-28       Impact factor: 14.819

Review 3.  Role of nitric oxide in immune responses against viruses: beyond microbicidal activity.

Authors:  Elaine Uchima Uehara; Beatriz de Stefano Shida; Cyro Alves de Brito
Journal:  Inflamm Res       Date:  2015-07-25       Impact factor: 4.575

4.  Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis.

Authors:  Resat Cinar; Malliga R Iyer; Ziyi Liu; Zongxian Cao; Tony Jourdan; Katalin Erdelyi; Grzegorz Godlewski; Gergő Szanda; Jie Liu; Joshua K Park; Bani Mukhopadhyay; Avi Z Rosenberg; Jeih-San Liow; Robin G Lorenz; Pal Pacher; Robert B Innis; George Kunos
Journal:  JCI Insight       Date:  2016-07-21

5.  Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis.

Authors:  Nursel Dilek; Aziz Ramazan Dilek; Yakup Taşkın; Taşkın Erkinüresin; Ömer Yalçın; Yunus Saral
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

6.  Selective gene expression profiling contributes to a better understanding of the molecular pathways underlying the histological changes observed after RHMVL.

Authors:  Janine Arlt; Sebastian Vlaic; Ronny Feuer; Maria Thomas; Utz Settmacher; Uta Dahmen; Olaf Dirsch
Journal:  BMC Med Genomics       Date:  2022-10-07       Impact factor: 3.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.